In recent years, several surveys have highlighted the presence of the rodent carcinogen furan in a variety of food items. Even though the evidence of carcinogenicity of furan is unequivocal, the underlying mechanism has not been fully elucidated. In particular, the role of genotoxicity in furan carcinogenicity is still not clear, even though this information is considered pivotal for the assessment of the risk posed by the presence of low doses of furan in food. In this work, the genotoxic potential of furan in vivo has been investigated in mice, under exposure conditions similar to those associated with cancer onset in the National Toxicology Program long-term bioassay. To this aim, male B6C3F1 mice were treated by gavage for 4 weeks with 2, 4, 8 and 15 mg furan/kg b.w./day. Spleen was selected as the target organ for genotoxicity assessment, in view of the capability of quiescent splenocytes to accumulate DNA damage induced by repeat dose exposure. The induction of primary DNA damage in splenocytes was evaluated by alkaline single-cell gel electrophoresis (comet assay) and by the immunofluorescence detection of foci of phosphorylated histone H2AX (g-H2AX). The presence of cross-links was probed in a modified comet assay, in which cells were irradiated in vitro with g-rays before electrophoresis. Chromosome damage was quantitated through the detection of micronuclei in mitogen-stimulated splenocytes using the cytokinesis-block method. Micronucleus induction was also assessed with a modified protocol, using the repair inhibitor 1-b-arabinofuranosyl-cytosine to convert singlestrand breaks in micronuclei. The results obtained show a significant (P < 0.01) increase of g-H2AX foci in mitogenstimulated splenocytes of mice treated with 8 and 15 mg furan/kg b.w. and a statistically significant (P < 0.001) increases of micronuclei in binucleated splenocytes cultured in vitro. Conversely, no effect of in vivo exposure to furan was observed when freshly isolated quiescent splenocytes were analysed by immunofluorescence and in comet assays, both with standard and radiation-modified protocols. These results indicate that the in vivo exposure to furan gives rise to pre-mutagenic DNA damage in resting splenocytes, which remains undetectable until it is converted in frank lesions during the S-phase upon mitogen stimulation. The resulting DNA strand breaks are visualized by the increase in g-H2AX foci and may originate micronuclei at the subsequent mitosis.
Introduction
Furan is a colourless volatile compound used in the chemical manufacturing industry as intermediate in the synthesis of a variety of polymers. Long-term bioassays with furan highlighted a distinct carcinogenic potential in Fisher 344/N rats and B6C3F1 mice, with liver as the main target organ in both species (1) . In rats, daily administration of doses as low as 2 mg/kg b.w. induced cholangiomas in nearly 100% of animals of both sexes; at higher doses, hepatocellular adenomas and carcinomas and mononuclear cell leukaemia were also significantly increased. In mice, low furan doses (8 and 15 mg/kg b.w./day) were associated with high incidences of hepatocellular adenomas and carcinomas in both males and females. In both species, numerous non-neoplastic liver lesions were also observed at sacrifice.
The sporadic occurrence of furan as flavour in some food items was reported since the seventies (2) . In more recent years, a survey of canned and jarred foods demonstrated the occurrence of furan in a variety of foods that undergo heat treatment, including baby food, at concentrations that may exceed 100 lg/kg of food (3) . Based on the analytical data available, upper dietary exposure levels to furan in the order of one to few micrograms per kilogram b.w. can be calculated, with relatively higher exposure figures for babies consuming canned food.
Considering the high effectiveness of furan as experimental carcinogen, a relatively small margin exists between furan doses carcinogenic in rodents and human exposure levels associated with dietary intake of furan. Whether this difference is sufficiently large to avoid health risks in the exposed population cannot be firmly established at present. In fact, uncertainties on the mechanism by which furan exerts its carcinogenic activity prevent a reliable assessment of risk at low doses (4) . To this aim, further studies on toxicity and mechanism of action of furan were recommended by the European Authority on Food Safety (5) . In this respect, the elucidation of the role of genotoxicity in the mechanism of action of furan plays a key role, in view of the possibility to define a no-observed-effect level and a tolerable human exposure level for non-genotoxic carcinogens (6) .
The available evidence of genotoxicity of furan mainly relies on in vitro studies, in which furan was generally negative in bacteria but showed mutagenic and clastogenic activity in mammalian cells, with and without metabolic activation (1, 7) . Positive results have also been reported with the furan metabolite cis-2-butene-1,4-dial in tests in bacteria (8) and in mammalian cells in vitro (9, 10) . Conversely, data on furan genotoxicity in vivo are controversial, with no clear positive result following oral exposure: the compound induced structural chromosomal aberrations, but not sister chromatid exchanges, in bone marrow cells of mice treated by intraperitoneal (i.p.) injection and did not induce unscheduled DNA synthesis in liver of rats and mice treated with single oral dose (1) . No information is available on the genotoxic effects elicited by furan when administered under the same treatment conditions applied in long-term studies. This information is especially relevant when the plausibility and the weight of evidence of a genotoxic mode of action is evaluated (11) and is of prioritary interest for the characterization of furan risk. Thus, an investigation was undertaken to assess the genotoxic effects induced in vivo in B6C3F1 mice by repeated oral administration of furan at the same dose levels applied in the National Toxicology Program (NTP) carcinogenicity bioassay, as well as after acute high-dose exposure. In this paper, we report the results of the analysis of DNA damage and micronuclei in spleen, a convenient target tissue for the detection of cumulative DNA damage induced by repeated exposure in vivo (12) .
Materials and methods

Animals
Male B6C3F1 mice aged 5-6 weeks were obtained from Harlan s.r.l. (Udine, Italy). Animals were housed in a room with a barrier system under standard environmental conditions (22 AE 2°C, 55 AE 15% relative humidity, on a 12-h light-dark cycle), with drinking water and laboratory rodent diet ad libitum. Experiments were carried out in compliance with the ethical provisions enforced by the European Union and authorized by the National Committee of the Italian Ministry of Health on the in vivo experimentation. Chemicals Furan (C 4 H 4 O, CAS 110-00-9) was purchased from Sigma-Aldrich Italia (Milan, Italy). The product tested (cat. no. 18,592-2) was .99% pure, stabilized with 0.025% of butylated hydroxytoluene. Fresh solutions of furan in corn oil (CAS 8001-30-7, from Sigma) were prepared before each experiment. Precautions were used in order to minimize evaporative losses during furan handling. For the preparation of test solutions, a known volume of furan was added to a weighted amount of corn oil, the solution weighted and adjusted to the final concentration adding the required amount of corn oil. Solutions of furan were quickly aliquoted in filled amber vials, one for each day of treatment, which were tightly sealed and stored at 4°C. The actual furan concentrations of test solutions was routinary checked by head-space capillary gas chromatography with flame ionization detector. The correlation coefficient of nominal and actual furan concentrations in corn oil solutions was .0.99.
Treatment of animals
After arrival, mice were assigned to treatment groups with similar average body weight and acclimatized 1 week in standard conditions. In acute experiments, furan was given once by gavage 3 h before sacrifice. In repeat dose experiments (one range-finding and one main experiment), furan was administered by gavage 5 days a week for 4 weeks and animals sacrificed by cervical dislocation 24 h after last administration. The delivered volume was 10 ml/kg b.w. in all cases. Methyl methanesulphonate (Sigma), dissolved in dimethylsulphoxide (DMSO) and administered by i.p. at 80 mg/kg b.w., was used as positive control. Animals were weighted once a week along treatment period. General health conditions were recorded daily.
Hystology and isolation of splenocytes After sacrifice, spleen was aseptically removed, weighted and cut symmetrically in two pieces along the longitudinal axis. One piece was fixed in 4% formaldehyde, embedded in paraffin blocks and cut into 5-lm sections that were mounted on glass slides. Sections were deparaffinized by heating at 60°C, washed in xylene and rehydrated through a graded series of ethanol:redistilled water washing. Sections were used for histological examination or for immunohistological analysis. For histological examination, sections were stained with haematoxylin and eosin and observed under a light microscope.
Single-cell suspension was prepared with the remaining spleen tissue through mechanical disgregation in cold RPMI 1640 medium (Gibco, Paisley, UK). Splenocytes were isolated by stratification on Hystopaque 1077 (Sigma), followed by centrifugation for 30 min at 390 g. After isolation, cells were washed twice in RPMI 1640 by centrifugation (10 min at 200 g) and immediately analysed by comet assay or used to set up duplicate cultures for micronucleus and c-H2AX analyses.
Cytokinesis-block micronucleus assay Splenocytes isolated as described above were used to set up cell cultures with 2 Â 10 6 cells/ml in RPMI 1640 medium with HEPES and Glutamine (Gibco) supplemented with 1% streptomycin-penicillin, 15% inactivated calf serum and Concanavalin A (Sigma) at a final concentration of 5 lg/ml. Cytochalasin-B (Sigma) was added 24 h after culture onset at a final concentration of 5 lg/ml. Binucleated cells were harvested after further 10 h of culture using a cytocentrifuge (Shandon, Waltham, MA, USA). After fixation in methanol for 10 min, slides were stained in 5% Giemsa solution in phosphate buffer. Slides were then coded and blind scored using a brightfield microscope. The frequency of micronucleated binucleated splenocytes was evaluated in 1000 binucleated cells per animal. The nuclear division index (NDI) (binucleated þ 2 Â multinucleated cells/total analysed cells) was determined to evaluate the rate of in vitro proliferation of stimulated spleen lymphocytes.
Cytokinesis-block micronucleus/1-b-arabinofuranosyl-cytosine protocol 1-b-Arabinofuranosyl-cytosine (Ara-C; from Sigma) was used to inihibit the gap-filling step of excision repair in stimulated splenocytes along the G 0 -G 1 phase (13) . Cell cycle length was evaluated in a preliminary experiment, in which splenocyte cultures from two mice were treated with BrdU (5-bromo-2-deoxyuridine) (5 lM) (Boehringer, Mannheim, Germany) soon after stimulation, and the appearance of labelled cells was evaluated 6, 8 and 10 h later by immunohistochemistry using an anti-BrdU anti-mouse IgG-FITC antibody (Boehringer). Based on the results obtained, 8 h was selected as an appropriate time interval for the exposure of stimulated splenocytes to Ara-C, allowing exposure of cells to the repair inhibitor during the cell cycle phase preceeding replicative DNA synthesis.
In the main experiment, parallel cultures were prepared by adding Ara-C at a final concentration of 1 lg/ml soon after culture initiation and removed 8 h later. After two washings with cold medium without serum, cultures were incubated for the remaining time in complete medium supplemented with 10 lg/ml of deoxycytidine (Sigma) and processed following the standard cytokinesis-block micronucleus assay (CBMN) assay protocol. The inhibitory effect of Ara-C on DNA repair, under the experimental conditions applied, was confirmed challenging in vitro isolated splenocytes with methyl methanesulphonate (200 lM, 2 h at 37°C), following a previously reported procedure (14) .
Alkaline comet assay
For comet assays, freshly isolated splenocytes were resuspended in phosphatebuffered saline (PBS) at 10 Â 10 6 cells/ml. The assay was performed essentially as described by Singh et al. (15) with minor modifications. Briefly, cells were suspended in 0.7% (w/v) low-melting point agarose (Bio-Rad Laboratory, Hercules, CA, USA) and sandwiched between a lower layer of 1% (w/v) normal-melting point agarose (Bio-Rad Labaratory) and a upper layer of 0.7% (w/v) low-melting point agarose on microscope slides (Carlo Erba, Milan, Italy). The slides were then immersed in a lysing solution (2.5 M NaCl, 100 mM Na 2 EDTA, 10 mM Tris, pH 10) containing 10% DMSO (Carlo Erba) and 1% Triton X-100 (Sigma), overnight at 4°C. At lysis completion, the slides were placed in a horizontal gel electrophoresis tank with fresh alkaline electrophoresis buffer (300 mM NaOH, 1 mM Na 2 EDTA, pH ! 13) and left in the solution for 25 min at 4°C to allow the DNA to unwind and the alkali-labile sites to express. Electrophoresis was carried out at 4°C for 25 min, 27 V (1 V/ cm) and 300 mA, using a Hoefer power supply (Pharmacia Biotech Inc., San Francisco, CA, USA). After electrophoresis, slides were immersed in 0.3 M sodium acetate in ethanol for 30 min. Slides were then dehydrated in absolute ethanol for 2 h and immersed for 5 min in 70% ethanol. Slides were air dried at room temperature. Immediately before scoring, slides were stained with 12-lg/ ml ethidium bromide (Sigma) and examined, at Â200 magnification, with an Olympus fluorescent microscope. Slides were analysed by a computerized image analysis system (Delta Sistemi, Rome, Italy). One hundred cells were scored for each experimental point from two different slides. To evaluate the amount of DNA damage, the fraction of total DNA in the tail (fraction of tail DNA) and tail length were used.
To specifically highlight the presence of DNA cross-links, a modified comet assay protocol was applied (16) . Briefly, slides prepared as for standard protocol were irradiated with 4 Gy Ce 137 -c-rays (dose-rate 0.891 Gy/min) just before the lysis step. All the following steps were the same as for the standard protocol.
Immunofluorescence techniques
Foci of phosphorylated histone H2AX (c-H2AX) were detected and quantitated both in freshly isolated splenocytes and in proliferating cells 24 h after stimulation with Concanavalin A. Cells were harvested by cytospin centrifugation at 20 g for 5 min, fixed 10 min in 4% formaldehyde and maintained in PBS 1Â at 4°C until immunofluorescent staining. To this aim, cells were permeabilized with 0.5% Triton X-100 for 10 min. After a blocking step in 10% bovine serum albumin, slides were immunostained with a mouse monoclonal IgG anti-phospho-histone H2A.X antibody (Ser139, clone JBW301, Upstate Biotechnology, Temecula, CA, USA), diluted 1:1000 in 3% goat serum/PBS 1Â and incubated in a humid chamber for 2 h at room temperature. Samples were washed two to three times for 10 min in a buffer containing PBS 1Â and 0.02% Tween 20 and processed with a goat anti-mouse IgG Alexa 488 secondary antibody (Invitrogen, Eugene, OR, USA) diluted 1:1000 in 3% goat serum/PBS 1Â and incubated in a humid chamber for 45 min at 37°C. After further washes, nuclear DNA was counterstained with 1 lg/ml 4#,6-diamidino-2-phenylindole (DAPI). Slides were mounted in Vectashield (Vector Laboratories, Burlingame, CA, USA) and analysed under a fluorescence microscope. Based on the number of c-H2AX foci, cells were classified in one of three classes: 0 signals, 1-9 signals or !10 signals. Two hundred unstimulated and four hundred proliferating splenocytes were analysed for each animal.
For the evaluation of apoptosis, a commercial kit for terminal dUTP nickend labelling (TUNEL) assay (Roche, Indianapolis, USA) was used. Tissue sections were permeabilized by proteinase K (20 min incubation at 37°C in a humid chamber) and then the TUNEL reaction mixture containing terminal deoxynucleotidyl transferase and the fluorescein isothiocyanate (FITC)-labelling solution was applied according to the instructions of the manufacturer. A DAPI solution in Vectashield antifade (Vector Laboratories) was used as counterstaining for the analysis of FITC-labelled nuclei. One thousand cells per each section were counted under a fluorescence microscope at Â400 magnification. DNase I-induced DNA strand breaks (3 U/ml, Sigma) served as positive control.
Statistical analysis
Mean frequencies of micronucleated splenocytes, c-H2AX foci and comet assay parameters in different experimental groups were compared by two-tailed Student's t test. The limit for statistical significance was set at P 5 0.05.
Results
General toxicity
A range-finding experiment was performed administering five furan doses, i.e. those tested in the NTP long-term bioassay (8 and 15 mg/kg b.w.) and three lower ones (1, 2, 4 mg/kg b.w.), to groups of three mice, 5 days a week for 4 weeks. No signs of overt toxicity were recorded during treatment period, and no effect on body weight gain, spleen weight and gross appearance was observed at sacrifice. In spleen sections stained in haematoxylin-eosin, no changes were observed in the architecture of the white pulp, considering both the T-cell area (the periarteriolar lymphoid sheaths) and the B-cell area (lymphoid follicles and marginal zones). Analogously, the haematogenous red pulp did not show any treatment-related modification. No significant increase of apoptotic cells was shown by TUNEL labelling of spleen sections of treated animals. Based on the lack of adverse effects, the dose levels of 2, 4, 8 and 15 mg/kg b.w. were selected for subsequent repeat dose experiments.
Micronucleus assays in cytokinesis-blocked splenocytes
A preliminary assessment of the cytogenetic effects of repeated furan administration was performed in mice used for the rangefinding toxicity experiment. A tendency to higher frequencies of micronuclei was observed in cytokinesis-blocked splenocytes of treated animals, even though this trend did not attain statistical significance, possibly due to the low number of animals analysed (data not shown). Based on these preliminary findings, a confirmatory main experiment with six animals per dose (eight vehicle controls) was performed at the doses of 2, 4, 8 and 15 mg furan/kg b.w. Data show a statistically significant increase of micronucleated cells in the spleen of furan-treated mice (Table I) . No influence of treatment on target cell viability and ability to proliferate was indicated by the NDI.
The possible induction of micronuclei in splenocytes of furan-treated mice was also evaluated using a modified experimental protocol, entailing the use of the DNA repair inhibitor Ara-C. Previous experience showed that the Ara-C protocol can increase the sensitivity of the CBMN, converting excisable DNA lesions in double-strand breaks (DSBs) visualized as micronuclei (13, 14) . Thus, in the main experiment described above, a parallel set of splenocyte cultures was incubated in presence of Ara-C for 8 h and then processed following the standard cytokinesis-block protocol. Exposure to Ara-C slightly delayed splenocyte growth in vitro, as shown by the lower NDI. Also with the modified protocol, however, a statistically significant increase of micronucleated splenocytes was observed cells from mice treated with the highest furan dose, as well as with one intermediate dose level (Table  I) . Compared to the standard protocol, the addition of Ara-C did not increase the difference between treatment and control values for each dose level. On the other hand, treatment of isolated splenocytes with methylmethansulphonate (200 lM) produced a larger increase on micronucleated cells in cultures incubated in presence of Ara-C compared to those processed with the standard protocol (59 and 33&, respectively), confirming the increased sensitivity of the modified method to DNA-damaging agents.
The influence of furan administration on micronucleus incidence in cytokinesis-blocked spleen lymphocytes was also evaluated in mice receiving furan as a single oral dose. Based on the results of a preliminary experiment and literature data (1), 250 mg/kg b.w. was selected as top dose. This dose level was well tolerated, with minimal sign of general toxicity, and no delayed growth of splenocytes in vitro, as shown by the NDI. The incidence of micronucleated splenocytes showed a treatment-related trend, which, however, did not attain statistical significance (Table II) .
Comet assays
The effect of furan administration on mice spleen cells was also evaluated with comet assay. To this aim, samples of freshly isolated splenocytes from vehicle and furan-treated mice were analysed with the standard alkaline (pH ! 13) protocol. Table III summarizes the results obtained with cells Five hundred binucleate cells scored. *P , 0.01; **P , 0.005;, ***P , 0.001 (Student's t test).
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harvested at the end of the 4-week exposure period. No clear treatment-related effect of furan administration on both parameters of DNA damage analysed (viz fraction of DNA in the tail and comet tail length) was observed. Sporadic increase of comet parameters can be attributed to rare heavily damaged cells, as shown by the distribution of damage within the cell populations analysed (Figure 1 ). The latter result may indicate some treatment-related toxicity or simply the random variation in rare apoptotic figures. Splenocytes of animals treated with 8 and 15 mg furan/kg b.w./day were also analysed with the modified protocol for cross-links: negative results were also obtained in this test (data not shown). As in repeat dose experiments, mice were sacrificed 24 h after last treatment; it is theoretically possible that short-lived DNA lesions induced by furan were repaired before comet assay. Thus, the assay was repeated on splenocytes of mice sacrificed 3 h after acute dosing. Also in this case, no treatment-related DNA damage was detected (Table IV) .
Analysis of c-H2AX
Foci of phosphorylated histone H2AX were detected by immunofluorescence in freshly isolated and mitogen-stimulated splenocytes of mice following 4 weeks administration of furan (Table V) . The results obtained show a statistically significant and consistent increase in the relative frequency of cells with high number of foci (.10 signals) in stimulated splenocytes of animals treated with the two highest furan doses (Figure 2) . Conversely, no effect of the in vivo exposure to furan was detected when c-H2AX foci were scored in freshly isolated quiescent splenocytes.
Discussion
The elucidation of the genotoxic potential plays a key role in cancer risk characterization because of the implications of genotoxicity in the estimation of risk at low doses. Different experimental evidences can be considered to evaluate the plausibility of a mutagenic mode of action for chemical carcinogens in increasing order of relevance, the evidence of mutagenicity from in vitro studies, DNA damage/genotoxicity detected in vivo in non-target tissues, the evidence of DNA damage in target tissues and finally gene mutations in relevant oncogenes/tumour suppressor genes in target tissues. Other discriminating criteria are temporality, being mutagenicity an early event in the process of carcinogenesis and dose-effect relationships, with mutagenicity generally observed at lower doses than tumours (11) .
In this study, the genotoxic potential of the rodent carcinogen furan was evaluated in a mouse strain susceptible to its carcinogenic effects, using the same route of administration and the same dose levels associated with tumour induction. Even though spleen is not identified as a target tissue of furan carcinogenicity in the mouse, in principle, this organ may provide important advantages in the assessment of genotoxicity in vivo under repeat exposure conditions. Differently from the proliferating bone marrow, in which furan produced consistent negative results (17) , quiescent spleen lymphocytes may accumulate unrepaired DNA damage during subchronic exposure in vivo. Cumulative damage can be fixed through DNA replication when splenocytes are stimulated to grow in vitro and be expressed as micronuclei at first mitosis in cytokinesis-blocked cells (12, 18) . Moreover, spleen lymphocytes are continuously recruited in the organ from blood, and thus, this cell type can be informative on internal exposure in a number of well-perfused districts, including liver.
In this work, 4 weeks oral exposure to relatively low furan doses, well below the maximum dose level recommended by genotoxicity test guidelines, produced clear evidence of genotoxicity, with statistically significant increases of micronucleated cells. A non-significant increase of micronucleated cells was observed following acute administration of furan at far higher dose levels. This discrepancy may indicate a saturation of metabolic capacities, with a less than proportional increase in the formation of ultimate cytotoxic and genotoxic metabolites, as also suggested by the relatively flat dose-effect relationship observed after repeated administration. Furthermore, the possible accumulation of DNA lesions in resting splenocytes must be considered. Even though furaninduced micronuclei were not characterized for centromere content, they can be considered an evidence of clastogenicity, in view of the insensitivity of splenocytes to aneugenic effects induced in vivo (12) . The observed clastogenic effect of furan may be ascribed to its conversion in the reactive metabolite cis-2-butene-1,4-dial by cytochrome CYP2E1. This bifunctional aldehyde may react with DNA forming covalent adducts with nucleosides, which have the potential to form DNA-DNA and DNA-protein cross-links (19, 20) . Cross-links are highly cytotoxic and clastogenic lesions, leading to the arrest of DNA replication and subsequent formation of DSBs (21) . The involvement of cross-links in the mechanism of clastogenicity of furan is supported by the formation of foci of c-H2AX in mitogen-stimulated cells. Histone H2AX is rapidly phosphorylated in response to DSB generation (22) , and the number of c-H2AX foci was shown to closely correspond to the number of DSB in the cell (23) . The immunofluorescence analysis of spleen cells of furan-treated mice highlighted a clear treatmentrelated excess of foci, but only following mitogen stimulation. This result indicates that furan exposure does not produce direct DSB but primary DNA damage, which is converted in DSB at DNA replication. Cross-links fit well within this picture, as H2AX phosphorylation has been shown to occur at replication fork stalled by interstrand cross-links (24) . Also the other experimental results obtained may be accommodated in this frame. Given the complexity of the repair of cross-links in mammalian cells, which involve multiple pathways in addition to nucleotide excision repair (21) , the amplification of micronucleus induction in vitro in presence of Ara-C is not anticipated, and indeed, it was not observed. On the other hand, the analysis of c-H2AX foci in quiescent and stimulated splenocytes demonstrated that DSBs are directly formed from damaged DNA at replication, with no need of Ara-C to convert simple excisable lesions in DSB. Also, the negative results of alkaline comet assays with freshly isolated splenocytes is fully compatible with the induction of crosslinks in vivo. This lesion is not expected to be detectable in comet assay under standard alkaline conditions, even though the presence of cross-links may be indirectly indicated by the reduction of DNA migration following irradiation (16) . In this work, no treatment-related effect was observed in comet assays, neither with the standard alkaline protocol nor with the radiation-modified method. Even though in principle crosslinks should produce a reduction in the migration of irradiated DNA, the relationship between damage and migration is complex, and the final outcome cannot easily be anticipated. In this respect, it is noteworthy that a recent study with cultured mammalian cells failed to show a reduction of comet tail length in irradiated cells after treatment with cis-2-butene-1,4-dial (10). Furthermore, it has been recently shown that the sensitivity of both standard and modified comet assay is not the same towards (25) .
In conclusion, the experimental results obtained provide the first evidence of genotoxicity of orally administered furan in mice. Even though the underlying mechanism is not fully elucidated, data support the formation of cross-links by the bifunctional furan metabolite cis-2-butene-1,4-dial as a plausible explanation. This finding adds confidence to the provisional conclusion of the European Authority on Food Safety on the probable involvement of genotoxicity in the mechanism of carcinogenicity of furan (5) . More conclusive information on the mode of action of furan is expected from the assessment of furan-induced genotoxicity in liver cells, the target tissue of furan carcinogenicity. Such work is in progress in our laboratory.
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